去甲斑蝥素脂质体的制备方法及理化性质研究

吴建梅;任天池

中国药学杂志 ›› 2005, Vol. 39 ›› Issue (19) : 1485-1489.

中国药学杂志 ›› 2005, Vol. 39 ›› Issue (19) : 1485-1489.
论著

去甲斑蝥素脂质体的制备方法及理化性质研究

  • 吴建梅;任天池
作者信息 +

Preparation and characterization of norcantharidin encapsulated in fiposome

  • WU Jian-mei1, REN Tian-chi2
Author information +
文章历史 +

摘要

目的筛选最佳去甲斑蝥素脂质体的制备方法并研究其理化性质。方法以包封率为测试指标,考察去甲斑蝥素脂质体的制备方法、药-脂比、胆固醇含量、荷电性、水相pH值、离子强度等因素,观察其显微结构并考察其粒径和粒度分布、体外释放特性及初步稳定性。结果采用薄膜分散法,药-脂比为1:20,磷脂-胆固醇比为2:1、水相介质pH为6.8的条件制备去甲斑螫素脂质体的包封率较高,可达47.5%。粒径约为360nm,体外释放度考察表明,在5h释放达到平衡,释放度为36.9%。在低温4℃条件下放置6个月,包封率和粒径基本没有变化。结论通过工艺和处方考察,优选出最佳的制备条件,制得的去甲斑蝥素脂质体包封率较高,比较稳定。

Abstract

OBJECTIVE To prepare and characterize the liposome containing norcantharidin. METHODS Entrapment efficiency was determined. The ratio of drug to phospholipids, the ratio of phospholipids to cholesterol, the electricity, the pH value of water and the iome. Strength of buffer solution were examined. The physico-chemical properties of norcantharidin encapsulated in liposome were also investigated. RESULTS The entrapped efficiency reached 47.5% by using film hydration method.The ratio of drug to lipids was 1:2.The ratio of phospholipids to cholesterol was 2:1 and pH of water phase was 6. 8. The release rate of norcantharidin from liposome was 36.9% after 5 h and 39.2% after 10 h. The study on the stability showed that norcantharidin liposome was stable at 4℃ for 6 monthes. CONCLUSION Norcantharidin liposome with high entrapped efficiency and stability can be obtained by the optimization of preparation and formulation.

关键词

去甲斑蝥素 / 脂质体 / 制备工艺

Key words

norcantharidin / liposome / preparation method / entrapped efficiency

引用本文

导出引用
吴建梅;任天池. 去甲斑蝥素脂质体的制备方法及理化性质研究[J]. 中国药学杂志, 2005, 39(19): 1485-1489
WU Jin-mei;REN Tin-chi. Preparation and characterization of norcantharidin encapsulated in fiposome [J]. Chinese Pharmaceutical Journal, 2005, 39(19): 1485-1489

参考文献

[1]王广生.斑蝥素水解及去甲基对其泌尿系统刺激的缓解[J].药学通报,1983,18 (7) :18. [2]Wang GS.MedicaL uses of mylabris in ancient and recent studies[J].J Ethnopharmacol,1989,26 :147. [3]孙骏奇,甘哲,王丽娟,等.去甲斑蝥素对实验性肝炎的药理研究Ⅰ.对四氯化碳中毒性肝损伤的保护作用[J].北京第二医学院学报,1985,6(4) :257. [4]温祥云,孙骏奇,甘哲,等.去甲斑蝥素对实验性肝炎的药理研究Ⅱ.去甲斑蝥素对正常肝脏毒性作用的病理形态学观察[J].北京第二医学院学报,1985,6(4):259. [5]董成.3H-去甲斑蝥素在小鼠体内分布的研究[J].江西医学院学报,1984,(1) :24. [6]潘卫三,孙稳健,胡晋.去甲斑蝥素毫微型胶囊制备方法的研究[J].沈阳药学院学报,1994,11(2):124. [7]程宇慧,廖工铁,侯世祥,等.去甲斑蝥酸钠白蛋白微球的研究[J].药学学报,1993,28(5) :384. [8]梁福佑,张胜华,潘颖,等.去甲斑蝥素用于单克隆抗体为载体的肿瘤导向治疗实验研究[J].首都医科大学学报,1999,20(1):5. [9]陆彬.药物新剂型与新技术[M]北京:人民卫生出版社,1998:115. [10]王广生,李荣昌,窦培延.去甲斑蝥素在胃肠液中的存在状态[J].药学通报,1984,19(8):24.

Accesses

Citation

Detail

段落导航
相关文章

/